AbbVie Faces 2nd Investor Suit Over Humira Kickbacks
AbbVie Inc. was hit with another proposed class action over its allegedly illegal strategy to market its blockbuster drug Humira, this one filed Tuesday by shareholders in Illinois federal court who...To view the full article, register now.
Already a subscriber? Click here to view full article